Skip to main content
Premium Trial:

Request an Annual Quote

Syrrx Hires Norman Halleen as Chief Financial Officer

NEW YORK, April 26 – Syrrx has appointed Norman Halleen to the position of vice president of finance and chief financial officer, a new position, the company said Thursday.

Halleen comes to the company from Aradigm, a maker of drug delivery systems, where he served as CFO and vice president of finance. 

Syrrx needed a CFO, said Nathaniel David, the company’s director of business development, because the company should be in a position to “examine other sources of financing,” including preparing for an initial public offering.

While David said the company has no immediate plans for an IPO, he added that hiring a CFO was important for a company of Syrrx’s size—meaning the number of employees and amount of money the company has to spend.

“It makes sense to prepare ourselves for more complex [financial] transactions,” David said.

Halleen will be responsible for finance, facilities, and investor relations for the company.
The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.